4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org

News

BioGenerator News

BAYER AWARDS $1.5 MILLION GRANT TO BIOGENERATOR’S PARENT COMPANY BIOSTL

Aug 06, 2019

ST. LOUIS, Aug. 6, 2019 – Bayer has awarded BioSTL, a St. Louis-based non-profit which advances and promotes the region’s growing bioscience, innovation and technology community, a $1.5 million grant […]

Read More

BioGenerator company MediBeacon enters into commercialization partnership with Huadong Medicine

Jul 31, 2019

MediBeacon Enters into $30 Million Investment and Exclusive Commercialization Partnership in Greater China with Huadong Medicine MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon’s entire […]

Read More

BioGenerator Wins $750,000 Federal Grant to Build New St. Louis Agtech Companies

Jul 24, 2019

Grant expands BioGenerator Labs and Commercialization Resources ST. LOUIS – BioGenerator, the investment arm of BioSTL, has won a $750,000 grant from the U.S. Department of Commerce Economic Development Administration […]

Read More

BioGenerator and Synchrony Bio lead initial financing for Readout, a Digital Health Startup

Jun 13, 2019

Readout adds veteran executive leadership to its management team ST. LOUIS – Readout, an early-stage digital health company, announced completion of its initial funding round, led by BioGenerator, the investment […]

Read More

BioGenerator Company Adarza BioSystems Reaches Commercialization Stage, Launches ZIVA Platform

May 02, 2019

Adarza BioSystems to reveal ZIVA platform at AAI 2019: a fully automated protein multiplex detection system ST. LOUIS (May 2, 2019) — Biotech startup Adarza Biosystems, Inc. announced today that […]

Read More

BioGenerator Company Canopy Biosciences Raises Series B Led By Ampersand, Acquires Zellkraftwerk

Apr 30, 2019

Press release:  https://canopybiosciences.com/news/canopy-biosciences-acquires-zellkraftwerk-gmbh/   Acquisition gives St. Louis-based Canopy an international reach Article by David Nicklaus Expanding internationally, being backed by a prominent private equity firm and tripling in size […]

Read More

Backed by Atlas Venture, BioGenerator Company Indalo Therapeutics Begins Clinical Program

Apr 18, 2019

Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965  – Oral integrin antagonist inhibits multiple processes of pathologic fibrosis – Indalo to present at […]

Read More

BioGenerator Company Arch Oncology Closes $50M Series B to Develop Best in Class Anti-CD-47 Therapies

Mar 25, 2019

BRISBANE, Calif. and ST. LOUIS–(BUSINESS WIRE)–Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class anti-CD47 antibody therapies, today announced a successful $50 million Series […]

Read More

BioGenerator Company Benson Hill Biosystems Continues Rapid Growth by Acquiring Schillinger Genetics

Mar 19, 2019

ST. LOUIS, MO—March 19, 2019—Benson Hill Biosystems, a crop improvement company unlocking the natural diversity of plants, announced today at the World Agri-Tech Innovation Summit that it has acquired the […]

Read More

Vaccine Breakthrough Published in Nature Communications Highlights Research of Startup VaxNewMo

Feb 21, 2019

BioGenerator-supported startup noted for its ‘promising process’ to more quickly and affordably bring vaccines to market   St. Louis bioscience startup VaxNewMo is developing broader and more affordable vaccines faster with […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors